ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk

In a recent study of our group with the acronym ACTIVATE, Bacillus Calmete-Guérin (BCG) vaccination reduced the occurrence of new infections compared to placebo vaccination in the elderly. Most benefit was found for respiratory infections. The ACTIVATE-2 study was launched to assess the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsilika, Maria, Taks, Esther, Dolianitis, Konstantinos, Kotsaki, Antigone, Leventogiannis, Konstantinos, Damoulari, Christina, Kostoula, Maria, Paneta, Maria, Adamis, Georgios, Papanikolaou, Ilias, Stamatelopoulos, Kimon, Bolanou, Amalia, Katsaros, Konstantinos, Delavinia, Christina, Perdios, Ioannis, Pandi, Aggeliki, Tsiakos, Konstantinos, Proios, Nektarios, Kalogianni, Emmanouela, Delis, Ioannis, Skliros, Efstathios, Akinosoglou, Karolina, Perdikouli, Aggeliki, Poulakou, Garyfallia, Milionis, Haralampos, Athanassopoulou, Eva, Kalpaki, Eleftheria, Efstratiou, Leda, Perraki, Varvara, Papadopoulos, Antonios, Netea, Mihai G., Giamarellos-Bourboulis, Evangelos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294453/
https://www.ncbi.nlm.nih.gov/pubmed/35865520
http://dx.doi.org/10.3389/fimmu.2022.873067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294453/
https://www.ncbi.nlm.nih.gov/pubmed/35865520
http://dx.doi.org/10.3389/fimmu.2022.873067

Ejemplares similares